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Abstract
BACKGROUND—The United States has a culturally and demographically diverse populace, and
the aim of this study was to examine differences in health preferences by gender, age, ethnicity,
and race.
METHODS—We assessed preferences for health outcomes defined by the PROMIS-29 survey in
a sample of the U.S. population. Based on the survey’s 540 paired comparisons trading off
lifespan and 7 domains of health-related quality of life (HRQoL), we compared the choices
between men and women, adults age 18 to 54 years and 55 years and older, Hispanics and non-
Hispanics and non-Hispanic Blacks and Whites. For each subgroup, we estimated the value of 122
HRQoL outcomes on a quality-adjusted life year (QALY) scale and tested for subgroup
differences.
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RESULTS—Compared to men, women preferred reduced lifespan over losses in HRQoL,
particularly for depression. Compared to the younger adults, older adults preferred reduced
lifespan over the symptoms of depression, anxiety, and fatigue. Compared to non-Hispanic
Whites, Hispanics preferred reduced lifespan over depression and sleep disturbance, but held
similar values on losses in physical functioning. Among non-Hispanics, Blacks preferred reduced
lifespan over losses in ability to climb stairs and to fall asleep compared to Whites, but held
similar values on mental health outcomes.
CONCLUSION—With the growing emphasis on patient-centeredness and culturally sensitive
treatment, it is important to recognize the diversity in values placed on potential losses in HRQoL,
particularly mental health outcomes. Demographic differences in preferences may influence
comparative or cost effectiveness of treatments as perceived by one or another subgroup.
Keywords
Quality-adjusted life years; discrete choice experiments; patient-reported outcomes; preferences;
Health-related Quality of Life (HRQoL)
INTRODUCTION
Demographic differences in health preferences are important considerations in health policy,
the implementation of clinical guidelines, medical decision making, and study design. Not
all decisions relating to public resources follow the “tyranny of the majority,” where the
majority interests are placed above those of a minority.(1) Health policy may allocate
greater authority to the preferences of a greatly affected minority (e.g., sickle-cell and
African Americans). Likewise, in clinical guidelines, it may be more appropriate to value
health outcomes from a specific perspective (e.g., women and menopausal symptoms).(2–5)
Physicians who wish to personalize treatments may prescribe differently or tailor clinic
protocols, because they take the time to inquire about the preferences of the patient in front
of them and account for the variability of preferences within the clinic populations.(6–8)
Knowledge of differences in health preferences also influences study design, particularly
quota sampling. For example, if men and women share values on all domains of health,
studies that oversample men or women would produce identical results (e.g., U.S. valuation
of the EQ-5D).(3, 9, 10)
In addition to health utility, differences in health preference may reflect differences in the
interpretation of patient-reported outcomes (PROs). The Patient-Reported Outcomes
Measurement Information System® (PROMIS®) includes publicly available health-related
quality of life (HRQoL) measures, such as the PROMIS-29.(11) The PROMIS initiative is a
network of NIH-funded research sites working to develop tools to measure health outcomes.
(12) Through a process known as item banking, PROMIS has established a catalog of
psychometric evidence on publicly available PRO items that measure key HRQoL domains.
The PROMIS-29 is an adult profile instrument available in English and Spanish that
measures 7 domains of HRQoL over the last 7 days with four 5-level (i.e., response
categories) items per domain, as well as an eighth domain (pain intensity) with a single 11-
level item.(13) For each domain, the 4 items were selected based on feedback from content
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experts and using item response theory to select the relatively more informative items.(14–
16)
The aim of the PROMIS Valuation Study is to value such PROs from the perspective of
adult members of the U.S. general population and cancer survivors.(17) Using data from
discrete choice experiments (DCEs) in the PROMIS Valuation Study,(18) we examined
differences in health preferences (i.e., values) by prominent demographic groups (gender,
age, ethnicity, and race) in the United States. This study applies quotas on each paired
comparison, thereby controlling for differential response by demographic characteristics.
Key to the analyses is the extent to which different sub-groups (e.g., males versus females)
are willing to trade off years of life to avoid decreases in functioning (physical or social) or
increases in symptom burden (anxiety, depression, fatigue, sleep disturbance, and pain).
METHODS
Theory Underlying Quality-Adjusted Life Year (QALY) and Choice
For the purposes of this study, values (V) are expressed on a QALY scale, where a year with
no health problems is 1 QALY. For example, a value of 10 QALYs would be associated
with 10 years with no health problems, and a value of 0 QALYS is associated with being
dead for 10 years. While sometimes used interchangeably, value and utility are different
concepts. For this paper, we define value as a preference-based measure representing the
choices of a group or subgroup of individuals (e.g., females), and utility as an unobserved
(latent) individual trait that governs a person’s choice (i.e., episodic random utility model).
(19–21) The 2 concepts are linked because value is inferred from the choices of multiple
individuals. Specifically, a paired-comparison task may ask a respondent which health
episodes he/she prefers: A or B? By definition, the episodes A and B have the same value
(VA=VB) if and only if exactly half of the respondents choose A instead of B. For example,
in the PROMIS-29 Valuation Study, some respondents were asked to choose between 10
years feeling “sometimes worthless, helpless, depressed, and hopeless” and a range of years
with “no health problems” followed by death (see Figure 1). The “50/50 mark” was
approximately 7.4 years (i.e., V [sometimes worthless, helpless, depressed and hopeless, 10
years] = 7.4 QALYs). When fewer or more respondents choose A instead of B, this
imbalance implies the extent of difference in value, VA-VB.
This study was designed to compare the values of 8 subgroups of respondents: gender (male;
females), age (18–54 years; 55 years or older), Hispanic ethnicity (Hispanic; non-Hispanic),
and race (non-Hispanic Black; non-Hispanic White). We hypothesize that subgroups of
respondents may disagree on the value of a health episode (i.e., the location of the 50/50
mark). Such differences can be assessed based on choice probabilities or based on the results
of a multi-attribute utility (MAU) regression. The MAU results have the advantage of
integrating across choice probabilities to describe decrements in value attributable to losses
in HRQoL. Each decrement, dh, is a downward shift on a QALY scale, which implies a
decrease in the likelihood of choosing a particular health episode.
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In the paired comparisons, 7 HRQoL domains (Physical Functioning, Anxiety, Depression,
Fatigue, Sleep Disturbance, Social Functioning, and Pain) were described using the
PROMIS-29 v1.0.(22) The pain domain has 2 subdomains (interference and intensity). The
first 6 domains and pain interference have four 5-category items each (i.e., 16 decrements
each). Pain intensity is assessed using a single 11-point numeric rating scale anchored
between no pain (0) and worse imaginable pain (10). Each loss in HRQoL (e.g., rarely
depressed) was expressed as lasting 10 years followed by death and parameterized using 122
decrements in value on a QALY scale (i.e., (7x16)+10 for pain). The duration of 10 years is
conventionally used in time trade-off tasks as a compromise between avoiding proximal
mortality (i.e., not too soon) and promoting realism for older respondents whose life
expectancy may not exceed 10 years.(23)
Survey
The PROMIS Valuation Study recruited U.S. respondents from 7 panel vendors, with each
vendor recruiting 1000 participants who completed the survey. To be eligible for the study,
respondents had to be 18 years or older and reside in the U.S. Each panel vendor sent its
members an e-mail invitation containing payment information and a member-specific
hyperlink that, once activated, opened the study’s informed consent page. After providing
informed consent, respondents completed the screener, self-reported health, DCE, and
follow-up components of the survey. The DCE component consisted of 30 paired
comparisons. An introduction to DCE demonstrated the concept of a paired comparison and
began with a choice between an apple and an orange. The next 2 examples illustrated the
range of difficulty in choosing between health scenarios with the understanding that the
respondent “must live in 1 of the 2 scenarios” (i.e., forced choice). First, respondents were
asked"which health scenario do you prefer? Good health for 10 years or poor health for 10
years,” followed by a second, more ambiguous example (bad vs. poor health) that
introduced the potential ambiguity of scenario descriptions.
Aside from the trade-off between HRQoL attributes, the 2 scenarios in a pair had a set of
attributes in common (i.e., pivot). This pivot was modified by 2 differences in attributes (i.e.,
bipedal partial profile).(24) For example, which do you prefer: 10 years in fair health (pivot)
with mild pain and no depression versus mild depression and no pain (biped)? For the first 6
pairs, the task directed respondents to choose between scenarios with either reduced lifespan
or 1 of 6 “health problems” for 10 years, including 3 levels of a depression symptom (rarely;
sometimes; or often feeling worthless, helpless, depressed, and hopeless) and 3 levels of
mild pain (1, 2, or 3 on a pain scale from 0 [no pain] to 10 [worst pain imaginable]). For the
remaining 24 pairs, the pivot was 10 years in Good, Fair, and Poor health with 2
compensating health problems (biped) followed by death (8 bipedal pairs with each pivot).
Each respondent in a panel was randomly assigned 1 of 1000 unique sequences of 30 pairs
based on his/her demographic characteristics (reported in survey and verified by vendor) to
guarantee that each pair-specific sample corresponds to demographic quotas. Each pair
choosing between reduced lifespan and health problem had between 571 and 772 responses
and each pair choosing between 2 health problems had between 359 and 398 responses. All
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study procedures were approved by the University of South Florida Institutional Review
Board (IRB # Pro00000076) and are described in greater detail in a report posted online.(9)
Statistical Analysis
For each of the 8 subgroups, demographic weights based on the 2010 U.S. Census were
applied to each paired-comparison response to calculate the subgroups’ 540 pair-specific
probabilities, p1…p540. Each probability was approximately normally distributed with
standard error, ó = sqrt(p × (1–p) /n).(25, 26) To estimate the 122 decrements in the MAU
regression for each subgroup, dh, we minimized the sum of squared error surrounding the
540 subgroups’ probabilities, , where P(.) was a cumulative
density function, dB/(dA+dB), and α was a scaling term that adjusts the proportional
relationship between P(.), and pk for 2 behavioral issues: satisficing (answering questions
without regard to content) (9, 27) and non-trading (i.e., price inelastic demand; consistently
choosing either reduced lifespan to avoid poor health or choosing poor health to avoid any
loss in lifespan).(17, 28) To assess the differences between subgroup values, p-values were
estimated by percentile bootstrap with pair-quota stratification and 1000 resampling
iterations. For purposes of presentation, we reported the sign of significant differences with
a p-value of 0.01 or less; however, the subgroup estimates and p-values are provided in the
Supplemental Digital Content 1.
RESULTS
Between March and July 2012, we recruited 29,031 respondents across the United States.
Among the 29% who met the survey requirements, 90% completed the survey with a median
duration of 20 minutes (interquartile range 16 to 28 minutes). Table 1 compares the
respondent characteristics to the 2010 U.S. Census, which was largely comparable due to
study design and due to quota sampling at the pair level.
For each of the 8 subgroups, 30 probabilities were estimated and illustrated as trends in
choice between reduced lifespan and levels of depression (Figure 2). As expected, reducing
lifespan (i.e., years of life lost ranging from 0 to 4 years) decreased the percentage of
respondents who preferred reduced lifespan over depression. Also, increasing frequency of
depression increased the percentage of respondents who preferred reduced lifespan over
depression.
The gap between the trend lines by gender, age, ethnicity, and race are summarized in Table
2, which shows that women preferred reduced lifespan over depression compared to men.
Adults age 55 or older preferred reduced lifespan over depression compared to younger
adults, and Hispanics preferred reduced lifespan over depression compared to non-
Hispanics. No differences in pain preferences were identified by gender or age; however,
Hispanic and Black adults preferred reduced lifespan over low levels of pain relative to non-
Hispanic and White respondents, respectively.
Table 3 describes significant demographic differences in value for the 122 losses in HRQoL
captured by the PROMIS-29. Women placed a higher value on 54 of the 122 losses in
Craig et al. Page 5






















HRQoL than men; however, these differences largely occurred at the extreme levels. Men
did not value any loss more than women (i.e., no minus signs in the columns comparing
values by gender). Older adults placed a higher value on anxiety, depression, and fatigue
than younger adults; however, younger adults valued 4 losses more than older adults (1
physical function, 1 social functioning, and 2 pain interference). Hispanics placed a higher
value on depression and sleep disturbance than non-Hispanics. Among non-Hispanics,
Blacks placed a higher value on reduced lifespan over losses in ability to climb stairs and to
fall asleep compared to Whites, but held similar values on mental health outcomes. Overall,
the results showed few significant differences in the value of social function and pain
interference, except between men and women at extreme social functioning and when pain
interferes with enjoyment of life. Differences in the value of pain intensity were not
significant (not shown in Table 3; see Supplemental Digital Content 1), except that women
valued levels 8, 9, and 10 (representing severe pain) more than men, and Blacks valued
levels 1, 2, and 3 more than Whites.
DISCUSSION
This paper examines the differences in health preferences by gender, age, ethnicity, and race
using a preference-based measure of 7 HRQoL domains. The results suggest that women
place a higher value on HRQoL than men, particularly on severe reductions. Likewise,
adults aged 55 and older value mental health more than younger adults. Few differences
were found by ethnicity and race, except for sleep disturbance and mild pain. The
differences by gender and age may be explained by differences in the value of lifespan or
shifts caused by health experiences that may favor HRQoL over longevity.
There are pros and cons to proposing an aggregate (or overall population-based) value set
versus a subgroup value set whose source preferences are aggregated on the basis of age,
race, or gender group, and their potential applications should first be carefully considered.
As Dolan stated, there are 3 questions we ask when calculating the “quality adjustment” part
of the QALY: What is to be valued? How is it to be valued? Who is to value it?(29) The
allocation of healthcare resources in government-funded healthcare systems typically uses
the preferences of the general population as the source of (societal) preferences to avoid
individual or subgroup self-interest. Further, if subgroup-based value sets were adopted for
resource allocation, the possibility of a “QALY trap” arises, which is biased against the
adoption of health technology in patient/respondents who systematically value health
outcomes higher.(30) Our present study identified a proportion of health-state pairs with
differences based on gender (49 of 122 pairs), older respondents compared to younger,(20)
and, to a much lesser extent, race/ethnicity. In contrast with our current study, previous
health valuation studies have found that race has an impact;(3) age also contributes to
different valuations,(3, 31) and presence of disease has produced inconsistent results.(32–
34) However, the use of subgroup-based value sets could inform treatment guidelines for
other purposes, such as understanding which health outcomes are more desirable to women
than men, which could then be extrapolated to personalized medicine. The threshold at
which to deem differences as meaningful enough to necessitate subgroup-based stratification
remains unclear.
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Aside from differences in preferences, a wide range of literature reports that depressive
symptoms are more accessible and more often expressed by women than men when they do
occur.(35) This suggests that moderate depression among women is similar to a lower level
of depression among men. In other words, a woman’s moderate level of depression is less
detrimental than a man’s moderate level. However, this study finds that women preferred
reduced lifespan over more severe levels of depression more than did men, which may
contribute to their greater motivation to express depression.
Research has demonstrated ethnic differences in reporting pain and in pain perceptions.(4, 5,
19, 35–39) The finding that Hispanics value mild levels of pain more than non-Hispanics is
consistent with previous research.(40–42) For example, Bates et al. (1993) found that
Hispanics report greater pain intensity as well as affective and sensory aspects of pain than
non-Hispanics. Rahim-Williams et al. (2007) found that Hispanics and non-Hispanic
African Americans reported greater pain sensitivity than non-Hispanic Whites on 3
experimental tests. In addition, there is some evidence supporting variations in pain intensity
assessment among race/ethnic subgroups.(40) Greater extreme response tendency has been
observed for Hispanics enrolled in Medicaid managed-care than Whites enrolled in
commercial managed-care on 0–10 global ratings of pain intensity.(43)
The PROMIS-29 profile questionnaire served as the basis for the DCEs. The PROMIS-29
selects 7 common outcome domains from a larger array of outcome domains to efficiently
represent the multidimensional concept of HRQoL. These domains (pain, fatigue, sleep,
depression, anxiety, physical function, and social function) do not include areas such as
cognitive function, anger, or other symptoms that might, for some people, also drive the way
health is valued and may be included in future research.
Limitations
Although this study provides important information on group-specific differences in health
preference ratings, some limitations are noted. First, even though the forced choice method
is widely applied in research, a limitation is that no qualitative study of these paired
comparisons was conducted. Second, the survey was conducted with people who can read
English. Generalizability to people with low literacy or to those who read and speak other
languages is not certain. This may limit generalizability to the Hispanics in the U.S. who can
read English and may, therefore, be more acculturated to U.S. society than their non-
English-speaking counterparts. Third, this study was conducted with a web-based survey,
thus those underserved populations without access are not represented. Although great care
was taken to validate respondent identities and apply demographic quota sampling at the
pair level to address potential biases in gender, age, and race/ethnicity groups, it should be
noted that the respondents for this study are experienced survey takers, thus, their responses
may not accurately reflect those of the general U.S. due to unobservable factors. Future
research may also examine the interaction of these demographic groups (e.g., older vs.
younger Hispanic respondents) and the effects of health on health preferences.
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This is the first valuation study conducted in the U.S. on the PROMIS measures. The
PROMIS initiative represents a significant investment by the NIH to standardize the
measurement of HRQoL to enhance healthcare research in the U.S. and globally. The
PROMIS measures are being used in clinical trials, comparative effectiveness research
studies, and population surveillance initiatives. As the PROMIS enables researchers to have
more reliable and valid HRQoL measures, to inform decision making and public policy, this
study serves a critical need to understand how different demographic populations of the U.S.
value such domains as physical and social function and symptoms including depression,
anxiety, sleep disturbance, and pain. This valuation study is a first step towards a broader
understanding of the valuing of health domains from a societal perspective. Follow-up
studies will compare U.S. general population values to cancer survivors. Recognizing these
differences allows decision makers to consider how health policies or interventions may
differentially impact the populations they serve.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
Financial support for this study was provided in part by an NCI R01 grant (1R01CA160104). Ron D. Hays was
supported in part by grants from the NIA (P30-AG021684) and the NIMHD (P20MD000182). The funding
agreement(s) ensured the authors’ independence in designing the study, interpreting the data, writing, and
publishing the report.
The authors thank Carol Templeton, Michelle Owens, and Shannon Hendrix-Buxton at Lee H. Moffitt Cancer
Center & Research Institute for their contributions to the research and creation of this paper. We also greatly
appreciate the external review comments from Dennis Fryback and David Feeny on the study methodology. The
opinions expressed in this paper do not represent those of these reviewers.
REFERENCES
1. Tocqueville, Ad. Democracy in America / by Alexis de Tocqueville. London: Saunders and Otley;
1835. ([London] : R. Taylor); 1835
2. Zarate V, Kind P, Chuang LH. Hispanic Valuation of the EQ-5D Health States: A Social Value Set
for Latin Americans. Value in Health. 2008; 11:1170–1177. [PubMed: 18489516]
3. Shaw JW, Johnson JA, Chen S, et al. Racial/ethnic differences in preferences for the EQ-5D health
states: results from the US valuation study. Journal of Clinical Epidemiology. 2007; 60:479–490.
[PubMed: 17419959]
4. Cykert S, Joines JD, Kissling G, et al. Racial differences in patients' perceptions of debilitated health
states. Journal of General Internal Medicine. 1999; 14:217–222. [PubMed: 10203633]
5. Luo N, Wang QN, Feeny D, et al. Measuring health preferences for Health Utilities Index Mark 3
health states: A study of feasibility and preference differences among ethnic groups in Singapore.
Medical Decision Making. 2007; 27:61–70. [PubMed: 17237454]
6. Burgess DJ, Gravely AA, Nelson DB, et al. A National Study of Racial Differences in Pain
Screening Rates in the VA Health Care System. Clinical Journal of Pain. 2013; 29:118–123.
[PubMed: 23183265]
7. Llewellynthomas HA, Sutherland HJ, Thiel EC. Do Patients' Evaluations of a Future Health State
Change When They Actually Enter That State? Medical Care. 1993; 31:1002–1012. [PubMed:
8231333]
Craig et al. Page 8






















8. Stiggelbout AM, Kiebert GM, Kievit J, et al. Utility Assessment in Cancer Patients: Adjustment of
Time Tradeoff Scores for the Utility of Life Years and 17 Comparison with Standard Gamble
Scores. Medical Decision Making. 1994; 14:82–90. [PubMed: 8152360]
9. Craig B, Reeve BB. Methods Report on the PROMIS Valuation Study: Year 1. 2012 Available at:
http://labpages.moffitt.org/craigb/Publications/Report120928.pdf.
10. Hadorn DC, Uebersax J. Large-Scale Health Outcomes Evaluation- How Should Quality-Of-Life
be Measured.1. Calibration of a Brief Questionnaire and a Search for Preference Subgroups.
Journal of Clinical Epidemiology. 1995; 48:607–618. [PubMed: 7730918]
11. Cella D, Riley W, Stone A, et al. The Patient-Reported Outcomes Measurement Information
System (PROMIS) developed and tested its first wave of adult selfreported health outcome item
banks: 2005-2008. Journal of Clinical Epidemiology. 2010; 63:1179–1194. [PubMed: 20685078]
12. NIH. PROMIS: Dynamic Tools to Measure Health Outcomes from the Patient Perspective. 2011
Available at: http://www.nihpromis.org/.
13. Revicki DA, Kawata AK, Harnam N, et al. Predicting EuroQol (EQ-5D) scores from the patient-
reported outcomes measurement information system (PROMIS) global items and domain item
banks in a United States sample. Quality of life research : an international journal of quality of life
aspects of treatment, care and rehabilitation. 2009; 18:783–791.
14. Reeve BB, Hays RD, Bjorner JB, et al. Psychometric evaluation and calibration of health-related
quality of life item banks - Plans for the patient-reported outcomes measurement information
system (PROMIS). Medical Care. 2007; 45:S22–S31. [PubMed: 17443115]
15. Cella D, Yount S, Rothrock N, et al. The Patient-Reported Outcomes Measurement Information
System (PROMIS) Progress of an NIH roadmap cooperative group during its first two years.
Medical Care. 2007; 45:S3–S11. [PubMed: 17443116]
16. DeWalt DA, Rothrock N, Yount S, et al. Evaluation of item candidates - The PROMIS qualitative
item review. Medical Care. 2007; 45:S12–S21. [PubMed: 17443114]
17. Craig BM, Busschbach JJV. Revisiting United States valuation of EQ-5D states. J Health Econ.
2011; 30:1057–1063. [PubMed: 21835477]
18. Craig BM, Reeve BB, Brown PM, et al. Valuation of Health Outcomes Measured Using the
PROMIS-29. J Health Econ [Under Review].
19. Bansback N, Brazier J, Tsuchiya A, et al. Using a discrete choice experiment to estimate health
state utility values. J Health Econ. 2012; 31:306–318. [PubMed: 22197308]
20. Craig BM, Busschbach JJ. The episodic random utility model unifies time trade-off and discrete
choice approaches in health state valuation. Popul Health Metr. 2009; 7:3. [PubMed: 19144115]
21. Hadorn DC, Hays RD, Uebersax J, et al. Improving task comprehension in the measurement of
health state preferences - a trial of informational cartoon figures and a paired-comparison task.
Journal of Clinical Epidemiology. 1992; 45:233–243. [PubMed: 1569420]
22. PROMIS-29 Profile v1.0. 2008-2012 Available at: https://www.assessmentcenter.net/ac1//
files/pdf/44b7636201a34267a9213db7f69f2c6d.pdf.
23. Feeny D. Standardization and regulatory guidelines may inhibit science and reduce the usefulness
of analyses based on the application of preference-based measures for policy decisions. Medical
decision making : an international journal of the Society for Medical Decision Making. 2013;
33:316–319. [PubMed: 23184461]
24. Chrzan K. Using partial profile choice experiments to handle large numbers of attributes.
International Journal of Market Research. 2010; 52:827–840.
25. Urban, FM. The Application of Statistical Methods to the Problems of Psychophysics.
Philadelphia: Psychological Clinic Press; 1908.
26. Urban, FM. Urban's Solution (Minimum Normit X2). In: Bock, RD.; Jones, LV., editors. The
Measurement and Prediction of Judgment and Choice. San Francisco: Holden-Day; 1968. p.
33-49.
27. Barge S, Gehlbach H. Using the Theory of Satisficing to Evaluate the Quality of Survey Data. Res
High Educ. 2012; 53:182–200.
28. Attema AE, Versteegh MM, Oppe M, et al. Lead Time to TTO: Leading to Better Health State
Evaluations? Health Economics. 2013; 22:376–392. [PubMed: 22396243]
Craig et al. Page 9






















29. Dolan P. Thinking About it: Thoughts About Health and Valuing QALYs. Health Economics.
2011; 20:1407–1416. [PubMed: 20967923]
30. Ubel PA, Richardson J, Menzel P. Societal value, the person trade-off, and the dilemma of whose
values to measure for cost-effectiveness analysis. Health Economics. 2000; 9:127–136. [PubMed:
10721014]
31. Dolan P. The effect of experience of illness on health state valuations. Journal of Clinical
Epidemiology. 1996; 49:551–564. [PubMed: 8636729]
32. Kind P, Dolan P. The Effect of Past and Present Illness Experience on the Valuations of Health
States. Medical Care. 1995; 33:AS255–AS263. [PubMed: 7723454]
33. Krabbe PFM, Tromp N, Ruers TJM, et al. Are patients' judgments of health status really different
from the general population? Health and Quality of Life Outcomes. 2011; 9
34. Pickard AS, Tawk R, Shaw JW. The effect of chronic conditions on stated preferences for health.
European Journal of Health Economics. 2013; 14:697–702. [PubMed: 22941035]
35. Van de Velde S, Bracke P, Levecque K. Gender differences in depression in European countries.
Cross-national variation in the gender gap in depression. Social Science & Medicine. 2010;
71:305–313. [PubMed: 20483518]
36. Ayalon L, King-Kallimanis BL. Trading Years for Perfect Health: Results From the Health and
Retirement Study. Journal of Aging and Health. 2010; 22:1184–1197. [PubMed: 20660638]
37. Hernandez A, Sachs-Ericsson N. Ethnic differences in pain reports and the moderating role of
depression in a community sample of Hispanic and Caucasian participants with serious health
problems. Psychosomatic Medicine. 2006; 68:121–128. [PubMed: 16449422]
38. Mulvaney-Day NE, Horvitz-Lennon M, Chen CN, et al. Valuing health in a racially and ethnically
diverse community sample: an analysis using the valuation metrics of money and time. Quality of
Life Research. 2010; 19:1529–1540. [PubMed: 20680690]
39. van der Pol M, Cairns J. Comparison of two methods of eliciting time preference for future health
states. Social Science & Medicine. 2008; 67:883–889. [PubMed: 18571298]
40. Bates MS, Edwards WT, Anderson KO. Ethnocultural influences on variation in chronic pain
perception. Pain. 1993; 52:101–112. [PubMed: 8446431]
41. Rahim-Williams FB, Riley JL, Herrera D, et al. Ethnic identity predicts experimental pain
sensitivity in African Americans and Hispanics. Pain. 2007; 129:177–184. [PubMed: 17296267]
42. Zinke JL, Lam CS, Harden RN, et al. Examining the Cross-cultural Validity of the English Short-
form McGill Pain Questionnaire Using the Matched Moderated Regression Methodology. Clinical
Journal of Pain. 2010; 26:153–162. [PubMed: 20090443]
43. Weech-Maldonado R, Elliott MN, Oluwole A, et al. Survey response style and differential use of
CAHPS rating scales by Hispanics. Medical Care. 2008; 46:963–968. [PubMed: 18725851]
Craig et al. Page 10























Example of a paired comparison: sometimes feeling worthless, helpless, depressed and
hopeless for 10 years vs. reduced lifespan with no health problems
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Percentage of respondents who prefer reduced lifespan vs. depression for 10 years by
gender, age, ethnicity, and race
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   18 to 34 28 (2125) 31
   35 to 54 36 (2711) 37
   55 and older 36 (2721) 33
Sex
   Male 48 (3657) 49
   Female 52 (3900) 51
Race
   White 84 (6195) 75
   Black or African American 12 (887) 12
   American Indian or Alaska Native 1 (53) 1
   Asian 2 (165) 5
   Native Hawaiian or other Pacific Islander <1 (34) <1
   Some other race - 5
   Two or more races 3 (223) 2
Hispanic ethnicity
   Hispanic or Latino 13 (972) 14
   Not Hispanic or Latino 87 (6585) 86
*
Demographic quota sampling was applied to each paired comparison to assure nationally representative estimates for each pair.
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